These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24142574)

  • 21. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
    Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
    Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.
    Christgen M; van Luttikhuizen JL; Raap M; Braubach P; Schmidt L; Jonigk D; Feuerhake F; Lehmann U; Schlegelberger B; Kreipe HH; Steinemann D
    Oncotarget; 2016 Dec; 7(50):82733-82740. PubMed ID: 27716627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer.
    Farabaugh SM; Chan BT; Cui X; Dearth RK; Lee AV
    Cell Commun Signal; 2016 Oct; 14(1):25. PubMed ID: 27765041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DNA structural features on the borders of ERBB2 amplicons in breast cancer].
    Matsenko NIu; Kovalenko SP
    Mol Biol (Mosk); 2013; 47(5):818-27. PubMed ID: 25509354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis.
    Li ZY; Dong YL; Feng Y; Zhang Z; Cao XZ
    J Cancer Res Ther; 2016; 12(2):1040-4. PubMed ID: 27461695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: a meta-analysis.
    Gómez Peña C; Dávila-Fajardo CL; Martínez-González LJ; Carmona-Sáez P; Soto Pino MJ; Sánchez Ramos J; Moreno Escobar E; Blancas I; Fernández JJ; Fernández D; Correa C; Cabeza Barrera J
    Pharmacogenet Genomics; 2015 Aug; 25(8):388-93. PubMed ID: 26049584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
    Turpin J; Ling C; Crosby EJ; Hartman ZC; Simond AM; Chodosh LA; Rennhack JP; Andrechek ER; Ozcelik J; Hallett M; Mills GB; Cardiff RD; Gray JW; Griffith OL; Muller WJ
    Oncogene; 2016 Nov; 35(47):6053-6064. PubMed ID: 27157621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
    Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
    Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of HER2 genetic polymorphisms on its protein expression in breast cancer.
    Su Y; Jiang Y; Sun S; Yin H; Shan M; Tao W; Ge X; Pang D
    Cancer Epidemiol; 2015 Dec; 39(6):1123-7. PubMed ID: 26323365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
    Akisik E; Dalay N
    Exp Mol Pathol; 2004 Jun; 76(3):260-3. PubMed ID: 15126109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression of the UROC28 gene in human breast cancer: relationship to ERBB2 gene expression.
    Kamagata C; Tsuji N; Kondoh K; Sasaki M; Kobayashi D; Yagihashi A; Watanabe N
    Anticancer Res; 2002; 22(6C):4087-91. PubMed ID: 12553037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.
    Desale SS; Raja SM; Kim JO; Mohapatra B; Soni KS; Luan H; Williams SH; Bielecki TA; Feng D; Storck M; Band V; Cohen SM; Band H; Bronich TK
    J Control Release; 2015 Jun; 208():59-66. PubMed ID: 25660204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [siRNA-mediated inhibition of ErbB2 expression and its effect on breast cancer cell growth].
    Jiang K; Yang ZH; Wang ZY; Xu XJ; Cheng L; Zhang H; Han YJ; Ye QN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):257-9. PubMed ID: 21419042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies.
    Yu D; Hung MC
    Oncogene; 2000 Dec; 19(53):6115-21. PubMed ID: 11156524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding common regions of alteration in copy number data.
    Rueda OM; Diaz-Uriarte R; Caldas C
    Methods Mol Biol; 2013; 973():339-53. PubMed ID: 23412800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
    Shimizu H; Seiki T; Asada M; Yoshimatsu K; Koyama N
    Oncogene; 2003 Feb; 22(6):831-9. PubMed ID: 12584562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.